Eosinophilic esophagitis (EoE) is an immune-mediated condition characterized by symptoms of esophageal dysfunction and an eosinophilic inflammation of the esophagus. Swallowed topical steroids represent one of the possible strategies for inducing and maintaining remission in EoE. To date, a validated maintenance strategy has yet to be defined, especially in children. The available evidence suggests decreasing the dose after a successful induction therapy. No study has reported the efficacy of a continuous progressive dose reduction; thus, it is unknown if all patients need to use the same dosages and for how long.

Maintenance therapy with the lowest effective dose of oral viscous budesonide in children with eosinophilic esophagitis / Oliva, S.; Volpe, D.; Russo, G.; Veraldi, S.; Papoff, P.; Giordano, C.; Ruggiero, C.; Trovato, C. M.; Terrin, G.; Rossetti, D.. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - (2021). [10.1016/j.cgh.2021.09.020]

Maintenance therapy with the lowest effective dose of oral viscous budesonide in children with eosinophilic esophagitis

Oliva S.
Primo
Writing – Original Draft Preparation
;
Volpe D.
Secondo
;
Russo G.;Veraldi S.;Papoff P.;Giordano C.;Trovato C. M.;Terrin G.
Penultimo
;
Rossetti D.
Ultimo
2021

Abstract

Eosinophilic esophagitis (EoE) is an immune-mediated condition characterized by symptoms of esophageal dysfunction and an eosinophilic inflammation of the esophagus. Swallowed topical steroids represent one of the possible strategies for inducing and maintaining remission in EoE. To date, a validated maintenance strategy has yet to be defined, especially in children. The available evidence suggests decreasing the dose after a successful induction therapy. No study has reported the efficacy of a continuous progressive dose reduction; thus, it is unknown if all patients need to use the same dosages and for how long.
2021
eosinophilic esophagitis; maintenance treatment; topical steroids
01 Pubblicazione su rivista::01a Articolo in rivista
Maintenance therapy with the lowest effective dose of oral viscous budesonide in children with eosinophilic esophagitis / Oliva, S.; Volpe, D.; Russo, G.; Veraldi, S.; Papoff, P.; Giordano, C.; Ruggiero, C.; Trovato, C. M.; Terrin, G.; Rossetti, D.. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - (2021). [10.1016/j.cgh.2021.09.020]
File allegati a questo prodotto
File Dimensione Formato  
Oliva_Maintenance therapy with_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.2 MB
Formato Adobe PDF
2.2 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1602785
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact